Atenolol versus losartan in children and young adults with Marfan's syndrome.
The New England journal of medicine.
Times cited: 98
Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.
American heart journal.
Times cited: 172